Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast for Scleredema Diabeticorum
NCT03512873Phase 1Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tranilast in scleredema diabeticorum, sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Volume change of skin lesions by ultrasound at 6 months. Status: unknown.
02
Drugs
tranilast
03
Conditions
scleredema diabeticorum
Beyond the preview
Go deeper on NCT03512873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512873.